{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:28:04Z","timestamp":1789684084866,"version":"4.0.1"},"reference-count":86,"publisher":"The Company of Biologists","issue":"9","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Consejo Nacional de Ciencia y Tecnolog\u00eda"},{"name":"Ministerio de Ciencia e Innovaci\u00f3n","award":["PID2022-136833OB-C22"],"award-info":[{"award-number":["PID2022-136833OB-C22"]}],"id":[{"id":"https:\/\/ror.org\/05r0vyz12","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) affects &amp;gt;30% of the global population and is increasing in prevalence to become the most common liver disorder. MASLD can influence distal organs via secreted mediators, and up to 43% of patients show sarcopenia or related muscle-wasting phenotypes. We developed a modular human three-dimensional bioengineered liver\u2013muscle platform to dissect causal liver\u2013muscle crosstalk. Liver constructs recapitulated steatosis and transition to metabolic dysfunction-associated steatohepatitis (MASH), with inflammatory, apoptotic, immune cell-recruiting and pro-fibrotic signatures. Transferring liver-derived conditioned media to engineered muscles revealed severity-dependent impairment of contractile performance, altered protein balance and myogenic regulation. Contractility declined progressively from steatosis to MASH. Steatotic liver conditioned media reduced myotube size, whereas MASH conditioned media triggered a compensatory program that partially preserved size despite functional loss. Muscle exposure to MASLD mediators was associated with disrupted autophagic degradation, consistent with impaired flux and accumulation of autophagosomes and lysosomes. This scalable human platform enables systematic investigation of MASLD extrahepatic mechanisms and provides a testbed for perturbations and interventions targeting liver-driven muscle wasting.<\/jats:p>","DOI":"10.1242\/dmm.052820","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:31:46Z","timestamp":1785393106000},"source":"Crossref","is-referenced-by-count":1,"title":["A bioengineered platform reveals progressive impairment of skeletal muscles by metabolic dysfunction-associated steatotic liver disease-derived factors"],"prefix":"10.1242","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3632-9898","authenticated-orcid":false,"given":"Armando","family":"Cort\u00e9s-Res\u00e9ndiz","sequence":"first","affiliation":[{"name":"Institute for Bioengineering of Catalonia (IBEC) 1 , 08028 Barcelona ,","place":["Spain"]},{"name":"Universitat Aut\u00f3noma de Barcelona (UAB) 2 , 08193 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1854-6082","authenticated-orcid":false,"given":"Juan M.","family":"Fern\u00e1ndez-Costa","sequence":"additional","affiliation":[{"name":"Institute for Bioengineering of Catalonia (IBEC) 1 , 08028 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-1401","authenticated-orcid":false,"given":"Maria","family":"Sabater-Arc\u00eds","sequence":"additional","affiliation":[{"name":"Institute for Bioengineering of Catalonia (IBEC) 1 , 08028 Barcelona ,","place":["Spain"]},{"name":"Neuromuscular Diseases Research Group, Institut de Recerca Sant Pau (IR SANT PAU), Hospital de la Santa Creu i Sant Pau 3 , 08041 Barcelona ,","place":["Spain"]},{"name":"CIBER de Enfermedades Raras, Instituto de Salud Carlos III 4 , 3-5 28029 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1537-1456","authenticated-orcid":false,"given":"Francesco","family":"De Chiara","sequence":"additional","affiliation":[{"name":"Institute for Bioengineering of Catalonia (IBEC) 1 , 08028 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3636-8013","authenticated-orcid":false,"given":"Javier","family":"Ram\u00f3n-Azc\u00f3n","sequence":"additional","affiliation":[{"name":"Institute for Bioengineering of Catalonia (IBEC) 1 , 08028 Barcelona ,","place":["Spain"]},{"name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats (ICREA) 5 , Passeig de Llu\u00eds Companys, 23, E08010 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026091706504693800_DMM052820C1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.27016","article-title":"Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer","volume":"60","author":"Aleksandrova","year":"2014","journal-title":"Hepatology"},{"key":"2026091706504693800_DMM052820C2","doi-asserted-by":"publisher","first-page":"G391","DOI":"10.1152\/ajpgi.00072.2023","article-title":"Albumin and fibrinogen synthesis rates in advanced chronic liver disease","volume":"325","author":"Amouzandeh","year":"2023","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2026091706504693800_DMM052820C3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00535-024-02098-8","article-title":"The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis","volume":"59","author":"Ampuero","year":"2024","journal-title":"J. Gastroenterol."},{"key":"2026091706504693800_DMM052820C4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1517\/17425255.2012.685159","article-title":"The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human","volume":"8","author":"Andersson","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"2026091706504693800_DMM052820C5","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.ajpath.2013.08.006","article-title":"Brucella abortus induces collagen deposition and MMP-9 down-modulation in hepatic stellate cells via TGF-\u03b21 production","volume":"183","author":"Arriola Benitez","year":"2013","journal-title":"Am. J. Pathol."},{"key":"2026091706504693800_DMM052820C6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2026091706504693800_DMM052820C7","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.29420","article-title":"Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis","volume":"66","author":"Bhanji","year":"2017","journal-title":"Hepatology"},{"key":"2026091706504693800_DMM052820C8","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.cgh.2017.04.004","article-title":"The long winding road to transplant: how sarcopenia and debility impact morbidity and mortality on the waitlist","volume":"15","author":"Bhanji","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2026091706504693800_DMM052820C9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12072-018-9875-9","article-title":"Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis","volume":"12","author":"Bhanji","year":"2018","journal-title":"Hepatol. Int."},{"key":"2026091706504693800_DMM052820C10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.phrs.2018.06.029","article-title":"Human-based systems: mechanistic NASH modelling just around the corner?","volume":"134","author":"Boeckmans","year":"2018","journal-title":"Pharmacol. Res."},{"key":"2026091706504693800_DMM052820C11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"2026091706504693800_DMM052820C83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","article-title":"The PDGF system and its antagonists in liver fibrosis","volume":"28","author":"Borkham-Kamphorst","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"2026091706504693800_DMM052820C12","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.jhepr.2024.101092","article-title":"Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants","volume":"6","author":"Bril","year":"2024","journal-title":"JHEP Rep."},{"key":"2026091706504693800_DMM052820C13","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.tiv.2023.105728","article-title":"3D multi-cell-type liver organoids: a new model of non-alcoholic fatty liver disease for drug safety assessments","volume":"94","author":"Bronsard","year":"2024","journal-title":"Toxicol. In Vitro"},{"key":"2026091706504693800_DMM052820C14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jcsm.12252","article-title":"Alterations in the in vitro and in vivo regulation of muscle regeneration in healthy ageing and the influence of sarcopenia","volume":"9","author":"Brzeszczy\u0144ska","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2026091706504693800_DMM052820C15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J. Obes. Metab. Syndr."},{"key":"2026091706504693800_DMM052820C16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"2026091706504693800_DMM052820C17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/TRA.12714\/","article-title":"Lysosomal size matters","volume":"21","author":"de Araujo","year":"2020","journal-title":"Traffic"},{"key":"2026091706504693800_DMM052820C18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1172\/JCI119207","article-title":"Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation","volume":"99","author":"De Benedetti","year":"1997","journal-title":"J. Clin. Investig."},{"key":"2026091706504693800_DMM052820C19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/biomedicines10050958","article-title":"Fatty hepatocytes induce skeletal muscle atrophy in vitro: a new 3D platform to study the protective effect of albumin in non-alcoholic fatty liver","volume":"10","author":"De Chiara","year":"2022","journal-title":"Biomedicines"},{"key":"2026091706504693800_DMM052820C20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/biomedicines12020453","article-title":"The tissue engineering revolution: from bench research to clinical reality","volume":"12","author":"De Chiara","year":"2024","journal-title":"Biomedicines"},{"key":"2026091706504693800_DMM052820C21","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3390\/IJMS26041778","article-title":"Current therapeutic landscape for metabolic dysfunction-associated steatohepatitis","volume":"26","author":"Devasia","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"2026091706504693800_DMM052820C22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026091706504693800_DMM052820C23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41467-020-20303-z","article-title":"Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH","volume":"12","author":"Dong","year":"2021","journal-title":"Nat. Commun."},{"key":"2026091706504693800_DMM052820C24","doi-asserted-by":"publisher","first-page":"e2410439","DOI":"10.1002\/advs.202410439","article-title":"Liver-secreted extracellular vesicles promote cirrhosis-associated skeletal muscle injury through mtDNA-cGAS\/STING Axis","volume":"12","author":"Fan","year":"2025","journal-title":"Adv. Sci."},{"key":"2026091706504693800_DMM052820C25","doi-asserted-by":"publisher","first-page":"E198","DOI":"10.1111\/hepr.12215","article-title":"Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells","volume":"44","author":"Feng","year":"2014","journal-title":"Hepatol. Res."},{"key":"2026091706504693800_DMM052820C26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12876-024-03192-0","article-title":"The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations","volume":"24","author":"Feng","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"2026091706504693800_DMM052820C27","doi-asserted-by":"publisher","first-page":"2200873","DOI":"10.1002\/admt.202200873","article-title":"Training-on-a-chip: a multi-organ device to study the effect of muscle exercise on insulin secretion in vitro","volume":"8","author":"Fern\u00e1ndez-Costa","year":"2023","journal-title":"Adv. Mater. Technol."},{"key":"2026091706504693800_DMM052820C28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-323-91821-3.00018-9","article-title":"Fundamentals and mechanisms","volume-title":"Multiscale Cell-Biomaterials Interplay in Musculoskeletal Tissue Engineering and Regenerative Medicine","author":"Fern\u00e1ndez-Costa","year":"2024"},{"key":"2026091706504693800_DMM052820C29","doi-asserted-by":"publisher","first-page":"21630","DOI":"10.1002\/jcp.28821","article-title":"Impact of different ectopic fat depots on cardiovascular and metabolic diseases","volume":"234","author":"Ferrara","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"2026091706504693800_DMM052820C30","doi-asserted-by":"publisher","first-page":"3018584","DOI":"10.1155\/2019\/3018584","article-title":"Increased circulating levels of interleukin-6 affect the redox balance in skeletal muscle","volume":"2019","author":"Forcina","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2026091706504693800_DMM052820C31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/biomedicines10010161","article-title":"From NAFLD to MAFLD: aligning translational in vitro research to clinical insights","volume":"10","author":"Gatzios","year":"2022","journal-title":"Biomedicines"},{"key":"2026091706504693800_DMM052820C32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41581-023-00692-2","article-title":"The role of lysosomes in metabolic and autoimmune diseases","volume":"19","author":"Gros","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"2026091706504693800_DMM052820C33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/hep4.1172","article-title":"Liver-enriched transcription factor expression relates to chronic hepatic failure in humans","volume":"2","author":"Guzman-Lepe","year":"2018","journal-title":"Hepatol. Commun."},{"key":"2026091706504693800_DMM052820C84","doi-asserted-by":"publisher","first-page":"14569","DOI":"10.1038\/s41598-021-93566-1","article-title":"Collagen and elastic fibres in acute and chronic liver injury","volume":"11","author":"Hall","year":"2021","journal-title":"Sci. Rep."},{"key":"2026091706504693800_DMM052820C34","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/jcsm.13103","article-title":"Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models","volume":"14","author":"Henrot","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2026091706504693800_DMM052820C35","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.21037\/atm-20-7269","article-title":"Inhibition of IL-6\/JAK\/STAT3 pathway rescues denervation-induced skeletal muscle atrophy","volume":"8","author":"Huang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"2026091706504693800_DMM052820C36","doi-asserted-by":"publisher","first-page":"109971","DOI":"10.1016\/j.celrep.2021.109971","article-title":"Integrated genomic and proteomic analyses identify stimulus-dependent molecular changes associated with distinct modes of skeletal muscle atrophy","volume":"37","author":"Hunt","year":"2021","journal-title":"Cell Rep."},{"key":"2026091706504693800_DMM052820C85","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/hep.21752","article-title":"Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes","volume":"46","author":"Joshi-Barve","year":"2007","journal-title":"Hepatology"},{"key":"2026091706504693800_DMM052820C37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5009\/gnl220543","article-title":"Sarcopenic obesity, the possible culprit for nonalcoholic fatty liver disease or fibrosis","volume":"17","author":"Kang","year":"2023","journal-title":"Gut Liver"},{"key":"2026091706504693800_DMM052820C38","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/jcsm.12598","article-title":"Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey","volume":"11","author":"Kang","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2026091706504693800_DMM052820C39","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.3390\/ijms25084405","article-title":"Role of epiregulin on lipopolysaccharide-induced hepatocarcinogenesis as a mediator via EGFR signaling in the cancer microenvironment","volume":"25","author":"Kubo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026091706504693800_DMM052820C40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medicina61020247","article-title":"Muscle strength and cardiovascular health in MASLD: a prospective study","volume":"61","author":"Kumbaro\u011flu","year":"2025","journal-title":"Medicina"},{"key":"2026091706504693800_DMM052820C41","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"2026091706504693800_DMM052820C42","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1128\/MCB.20.9.3256-3265.2000","article-title":"Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways","volume":"20","author":"Lawlor","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"2026091706504693800_DMM052820C43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"2026091706504693800_DMM052820C44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"key":"2026091706504693800_DMM052820C45","doi-asserted-by":"publisher","first-page":"100197","DOI":"10.1016\/j.jhepr.2020.100197","article-title":"Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD","volume":"3","author":"Linge","year":"2021","journal-title":"JHEP Rep."},{"key":"2026091706504693800_DMM052820C46","doi-asserted-by":"publisher","first-page":"829245","DOI":"10.3389\/fmed.2022.829245","article-title":"High interleukin-8 levels associated with decreased survival in patients with cirrhosis following transjugular intrahepatic portosystemic shunt","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Med."},{"key":"2026091706504693800_DMM052820C47","doi-asserted-by":"publisher","first-page":"19675","DOI":"10.1002\/jcp.28568","article-title":"Interleukin-8 enhances myocilin expression, Akt-FoxO3 signaling and myogenic differentiation in rat skeletal muscle cells","volume":"234","author":"Milewska","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"2026091706504693800_DMM052820C48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Montano-Loza","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2026091706504693800_DMM052820C49","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2337\/db22-0590","article-title":"Liver-secreted hexosaminidase a regulates insulin-like growth factor signaling and glucose transport in skeletal muscle","volume":"72","author":"Montgomery","year":"2023","journal-title":"Diabetes"},{"key":"2026091706504693800_DMM052820C50","doi-asserted-by":"publisher","first-page":"2201618","DOI":"10.1002\/admi.202201618","article-title":"Organs-on-chips: trends and challenges in advanced systems integration","volume":"9","author":"Mughal","year":"2022","journal-title":"Adv. Mater. Interfaces"},{"key":"2026091706504693800_DMM052820C51","doi-asserted-by":"publisher","first-page":"dmm050540","DOI":"10.1242\/dmm.050540","article-title":"Taurine activates the AKT\u2013mTOR axis to restore muscle mass and contractile strength in human 3D in vitro models of steroid myopathy","volume":"17","author":"Mughal","year":"2024","journal-title":"Dis. Model. Mech."},{"key":"2026091706504693800_DMM052820C52","doi-asserted-by":"publisher","first-page":"045006","DOI":"10.1088\/1758-5090\/adf66c","article-title":"Metabolic adaptation and fragility in healthy 3D in vitro skeletal muscle tissues exposed to chronic fatigue syndrome and Long COVID-19 sera","volume":"17","author":"Mughal","year":"2025","journal-title":"Biofabrication"},{"key":"2026091706504693800_DMM052820C53","doi-asserted-by":"publisher","first-page":"15360","DOI":"10.1038\/s41598-018-33840-x","article-title":"Obese subcutaneous adipose tissue impairs human myogenesis, particularly in old skeletal muscle, via resistin-mediated activation of NF\u03baB","volume":"8","author":"O'Leary","year":"2018","journal-title":"Sci. Rep."},{"key":"2026091706504693800_DMM052820C54","doi-asserted-by":"publisher","first-page":"e0182040","DOI":"10.1371\/journal.pone.0182040","article-title":"Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-\u03baB signaling pathway and myoblast-derived tumor necrosis factor-\u03b1","volume":"12","author":"Ono","year":"2017","journal-title":"PLoS ONE"},{"key":"2026091706504693800_DMM052820C55","doi-asserted-by":"publisher","first-page":"155577","DOI":"10.1016\/j.metabol.2023.155577","article-title":"Interplay of skeletal muscle and adipose tissue: sarcopenic obesity","volume":"144","author":"Park","year":"2023","journal-title":"Metabolism"},{"key":"2026091706504693800_DMM052820C56","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/cells10071816","article-title":"Sustained systemic levels of IL-6 impinge early muscle growth and induce muscle atrophy and wasting in adulthood","volume":"10","author":"Pelosi","year":"2021","journal-title":"Cells"},{"key":"2026091706504693800_DMM052820C57","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/liv.14942","article-title":"Experimental liver models: from cell culture techniques to microfluidic organs-on-chip","volume":"41","author":"Polidoro","year":"2021","journal-title":"Liver Int."},{"key":"2026091706504693800_DMM052820C58","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1039\/D5LC00614G","article-title":"Myo-MOVES: a custom electrical stimulation system for functional studies of 3D bioengineered muscle","volume":"25","author":"Ruiz-Guti\u00e9rrez","year":"2025","journal-title":"Lab. Chip"},{"key":"2026091706504693800_DMM052820C59","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.omtn.2021.08.010","article-title":"Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression","volume":"25","author":"Sabater-Arcis","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2026091706504693800_DMM052820C60","doi-asserted-by":"publisher","first-page":"1433857","DOI":"10.3389\/fcell.2024.1433857","article-title":"Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases","volume":"12","author":"Sandireddy","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"2026091706504693800_DMM052820C61","doi-asserted-by":"publisher","first-page":"13222","DOI":"10.3390\/ijms241713222","article-title":"Saturated fat-mediated upregulation of IL-32 and CCL20 in hepatocytes contributes to higher expression of these fibrosis-driving molecules in MASLD","volume":"24","author":"Schilcher","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"2026091706504693800_DMM052820C62","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"2026091706504693800_DMM052820C86","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: From physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J. Hepatol."},{"key":"2026091706504693800_DMM052820C63","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","article-title":"Cellpose: a generalist algorithm for cellular segmentation","volume":"18","author":"Stringer","year":"2021","journal-title":"Nat. Methods"},{"key":"2026091706504693800_DMM052820C64","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00125-024-06196-3","article-title":"EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): executive summary","volume":"67","author":"Tacke","year":"2024","journal-title":"Diabetologia"},{"key":"2026091706504693800_DMM052820C65","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1074\/jbc.M109.085431","article-title":"MicroRNAs regulate human hepatocyte nuclear factor 4\u03b1, modulating the expression of metabolic enzymes and cell cycle","volume":"285","author":"Takagi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2026091706504693800_DMM052820C66","doi-asserted-by":"publisher","first-page":"1050049","DOI":"10.3389\/fendo.2023.1050049","article-title":"Identification of shared genetic architecture between non-alcoholic fatty liver disease and type 2 diabetes: a genome-wide analysis","volume":"14","author":"Tan","year":"2023","journal-title":"Front. Endocrinol."},{"key":"2026091706504693800_DMM052820C67","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cgh.2016.04.040","article-title":"A model to identify sarcopenia in patients with cirrhosis","volume":"14","author":"Tandon","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2026091706504693800_DMM052820C68","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","article-title":"Sarcopenia and frailty in decompensated cirrhosis","volume":"75","author":"Tandon","year":"2021","journal-title":"J. Hepatol."},{"key":"2026091706504693800_DMM052820C69","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and autophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"2026091706504693800_DMM052820C70","doi-asserted-by":"publisher","first-page":"045024","DOI":"10.1088\/1758-5090\/acfb3d","article-title":"Mimicking sarcolemmal damage in vitro: a contractile 3D model of skeletal muscle for drug testing in Duchenne muscular dystrophy","volume":"15","author":"Tejedera-Villafranca","year":"2023","journal-title":"Biofabrication"},{"key":"2026091706504693800_DMM052820C71","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2026091706504693800_DMM052820C72","doi-asserted-by":"publisher","first-page":"M326","DOI":"10.1093\/gerona\/57.5.M326","article-title":"Relationship of interleukin-6 and tumor necrosis factor-\u03b1 with muscle mass and muscle strength in elderly men and women: the health ABC study","volume":"57","author":"Visser","year":"2002","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"2026091706504693800_DMM052820C73","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4254\/wjh.v16.i2.152","article-title":"Metabolic-associated fatty liver disease and sarcopenia: a double whammy","volume":"16","author":"Viswanath","year":"2024","journal-title":"World J. Hepatol."},{"key":"2026091706504693800_DMM052820C74","doi-asserted-by":"publisher","first-page":"23829","DOI":"10.1038\/s41598-024-75713-6","article-title":"Deletion of platelet-derived growth factor receptor \u03b2 suppresses tumorigenesis in metabolic dysfunction-associated steatohepatitis (MASH) mice with diabetes","volume":"14","author":"Wada","year":"2024","journal-title":"Sci. Rep."},{"key":"2026091706504693800_DMM052820C75","doi-asserted-by":"publisher","first-page":"11793","DOI":"10.1038\/s41598-021-91191-6","article-title":"Automatic and unbiased segmentation and quantification of myofibers in skeletal muscle","volume":"11","author":"Waisman","year":"2021","journal-title":"Sci. Rep."},{"key":"2026091706504693800_DMM052820C76","doi-asserted-by":"publisher","first-page":"e75692","DOI":"10.1371\/journal.pone.0075692","article-title":"Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2","volume":"8","author":"Weiskirchen","year":"2013","journal-title":"PLoS ONE"},{"key":"2026091706504693800_DMM052820C77","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"2026091706504693800_DMM052820C78","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1083\/jcb.111.4.1623","article-title":"Regulation of proliferation and differentiation of myoblasts derived from adult mouse skeletal muscle by specific isoforms of PDGF","volume":"111","author":"Yablonka-Reuveni","year":"1990","journal-title":"J. Cell Biol."},{"key":"2026091706504693800_DMM052820C79","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"2026091706504693800_DMM052820C80","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"2026091706504693800_DMM052820C81","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00204-022-03265-7","article-title":"In vitro modeling of liver fibrosis in 3D microtissues using scalable micropatterning system","volume":"96","author":"Zahmatkesh","year":"2022","journal-title":"Arch. Toxicol."},{"key":"2026091706504693800_DMM052820C82","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.semcdb.2017.11.011","article-title":"Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis","volume":"72","author":"Zammit","year":"2017","journal-title":"Semin. Cell Dev. Biol."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052820\/3710744\/dmm052820.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052820\/3718106\/dmm052820.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052820\/3718106\/dmm052820.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:50:55Z","timestamp":1789642255000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/19\/9\/dmm052820\/372938\/A-bioengineered-platform-reveals-progressive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.052820","relation":{},"ISSN":["1754-8403","1754-8411"],"issn-type":[{"value":"1754-8403","type":"print"},{"value":"1754-8411","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"dmm052820"}}